Role of CDH1 promoter methylation in colorectal carcinogenesis: A meta-analysis

DNA and Cell Biology

Volumn 33, Issue 7, 2014, Pages 455-462

  Li, Yu Xi ^a   Lu, Yao ^a   Li, Chun Yu ^a   Yuan, Peng ^a   Lin, Shu Sen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; UVOMORULIN;

AFRICA; ARTICLE; ASIAN; CANCER DIAGNOSIS; CANCER PATIENT; CANCER TISSUE; CAUCASIAN; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOGENESIS; DATA BASE; DNA METHYLATION; EARLY DIAGNOSIS; GENE FREQUENCY; HUMAN; META ANALYSIS; PATHOGENESIS; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION;

CADHERINS; COLORECTAL NEOPLASMS; DATABASES AS TOPIC; DNA METHYLATION; HUMANS; MULTIVARIATE ANALYSIS; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84903312414     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2291     Document Type: Article

References (38)

1. Baranwal, S., and Alahari, S.K. (2009). Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem Biophys Res Commun 384, 6-11.
2. Behrens, J., Lowrick, O., Klein-Hitpass, L., and Birchmeier, W. (1991). The E-cadherin promoter: functional analysis of a GC-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci U S A 88, 11495-11499. (Pubitemid 21916068)
3. Chan, A.T., and Giovannucci, E.L. (2010). Primary prevention of colorectal cancer. Gastroenterology 138, 2029- 2043.e2010.
4. Christofori, G., and Semb, H. (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24, 73-76. (Pubitemid 29346577)
5. Cunningham, D., Atkin, W., Lenz, H.J., Lynch, H.T., Minsky, B., Nordlinger, B., and Starling, N. (2010). Colorectal cancer. Lancet 375, 1030-1047.
6. Darwanto, A., Kitazawa, R., Maeda, S., and Kitazawa, S. (2003). MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma. Cancer Sci 94, 442-447. (Pubitemid 36790477)
7. Desotelle, J., Truong, M., Ewald, J., Weeratunga, P., Yang, B., Huang, W., and Jarrard, D. (2013). CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer. J Urol 189, 329-335.
8. Dorudi, S., Hanby, A.M., Poulsom, R., Northover, J., and Hart, I.R. (1995). Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71, 614-616.
9. Elzagheid, A., Buhmeida, A., Laato, M., El-Faitori, O., Syrjanen, K., Collan, Y., and Pyrhonen, S. (2012). Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma. APMIS 120, 539-548.
10. Garrity-Park, M.M., Loftus, E.V., Jr., Sandborn, W.J., Bryant, S.C., and Smyrk, T.C. (2010). Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitisassociated colorectal cancer. Am J Gastroenterol 105, 1610- 1619.
11. Grunhage, F., Jungck, M., Lamberti, C., Berg, C., Becker, U., Schulte-Witte, H., Plassmann, D., Rahner, N., et al. (2008). Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int J Colorectal Dis 23, 147-154. (Pubitemid 350302510)
12. Halvey, P.J., Zhang, B., Coffey, R.J., Liebler, D.C., and Slebos, R.J. (2012). Proteomic consequences of a single gene mutation in a colorectal cancer model. J Proteome Res 11, 1184- 1195.
13. Hamilton, W., and Sharp, D. (2004). Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Fam Pract 21, 99-106. (Pubitemid 38240349)
14. Hong, L., and Ahuja, N. (2013). DNA methylation biomarkers of stool and blood for early detection of colon cancer. Genet Test Mol Biomarkers 17, 401-406.
15. Huang, M.J., Wang, J.P., Chu, Z.H., Cai, S.R., Yang, Z.L., and Wang, L. (2005). Relationship between E-cadherin gene methylation and clinicopathological characteristics of colorectal cancer. Chin J Exper Surg 22, 1355-1356.
16. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J Clin 61, 69-90.
17. Kang, H.J., Kim, E.J., Kim, B.G., You, C.H., Lee, S.Y., Kim, D.I., and Hong, Y.S. (2012). Quantitative analysis of cancerassociated gene methylation connected to risk factors in Korean colorectal cancer patients. J Prev Med Public Health 45, 251-258.
18. Kim, M.S., Lee, J., and Sidransky, D. (2010). DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29, 181- 206.
19. Lee, S., Hwang, K.S., Lee, H.J., Kim, J.S., and Kang, G.H. (2004). Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84, 884-893. (Pubitemid 38833248)
20. Li, C., Dong, J., Chen, M.Q., Li, W.L., Ren, J.Y., Chen, S.X., Li, Q.T., Geng, J.W., et al. (2011). Effects of CDH1 gene promoter methylation on expression of E-cadherin and betacatenin and its clinicopathological significance in colon carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi 14, 538-541.
21. Li, L., Hartley, R., Reiss, B., Sun, Y., Pu, J., Wu, D., Lin, F., Hoang, T., et al. (2012). E-cadherin plays an essential role in collective directional migration of large epithelial sheets. Cell Mol Life Sci 69, 2779-2789.
22. Lin, S.Y., Yeh, K.T., Chen, W.T., Chen, H.C., Chen, S.T., Chiou, H.Y., and Chang, J.G. (2004). Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features. Oncol Rep 11, 341-348.
23. Miladi-Abdennadher, I., Abdelmaksoud-Damak, R., Ayadi, L., Khabir, A., Frikha, F., Kallel, L., Amouri, A., Frikha, M., et al. (2010). Hypermethylation of RARbeta2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma. Tumour Biol 31, 503-511.
24. Muller, H.M., Oberwalder, M., Fiegl, H., Morandell, M., Goebel, G., Zitt, M., Muhlthaler, M., Ofner, D., et al. (2004). Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363, 1283-1285.
25. Peters, J.L., Sutton, A.J., Jones, D.R., Abrams, K.R., and Rushton, L. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295, 676-680. (Pubitemid 43209069)
26. Schmalhofer, O., Brabletz, S., and Brabletz, T. (2009). E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28, 151-166.
27. Schrader, K.A., Masciari, S., Boyd, N., Salamanca, C., Senz, J., Saunders, D.N., Yorida, E., Maines-Bandiera, S., et al. (2011). Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet 48, 64-68.
28. Shirkoohi, R. (2013). Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance. Cancer Sci 104, 28-35.
29. Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603-605.
30. Stoops, S.L., Pearson, A.S., Weaver, C., Waterson, A.G., Days, E., Farmer, C., Brady, S., Weaver, C.D., et al. (2011). Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells. ACS Chem Biol 6, 452-465.
31. Toyooka, S., Toyooka, K.O., Harada, K., Miyajima, K., Makarla, P., Sathyanarayana, U.G., Yin, J., Sato, F., et al. (2002). Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Res 62, 3382-3386. (Pubitemid 34651383)
32. Van den Bossche, J., Malissen, B., Mantovani, A., De Baetselier, P., and Van Ginderachter, J.A. (2012). Regulation and function of the E-cadherin/catenin complex in cells of the monocytemacrophage lineage and DCs. Blood 119, 1623-1633.
33. Wang, L., Wang, Z., Yuan, X., Jiao, N.L., Zhang, Y.W., and Tong, J.D. (2012). Methylation of CDH13 gene in colorectal cancer and its clinical significance. Jiangsu Med J 38, 199-201.
34. Watson, A.J., and Collins, P.D. (2011). Colon cancer: a civilization disorder. Dig Dis 29, 222-228.
35. Wheeler, J.M., Kim, H.C., Efstathiou, J.A., Ilyas, M., Mortensen, N.J., and Bodmer, W.F. (2001). Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer. Gut 48, 367-371. (Pubitemid 32269565)
36. Xiong, H., Hong, J., Du, W., Lin, Y.W., Ren, L.L., Wang, Y.C., Su, W.Y., Wang, J.L., et al. (2012). Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. J Biol Chem 287, 5819-5832.
37. Zhao, X., Song, H., Zuo, Z., Zhu, Y., Dong, X., and Lu, X. (2013). Identification of miRNA-miRNA synergistic relationships in colorectal cancer. Int J Biol Macromol 55, 98-103.
38. Zintzaras, E., and Ioannidis, J.P. (2005). HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics 21, 3672-3673. (Pubitemid 41264106)